Dirk Rodgers

Contributing Editor. Founder, RxTrace.com

Healthcare Packaging's UDI Resource Guide

Exclusive 2019 medical device labeling resource guide

Healthcare Packaging’s UDI Resource Guide provides over 30 links to Unique Device Identification compliance resources.

The future of the cannabis supply chains

Is it time to break the cannabis supply chain into two separate discussions?

Can lessons from pharma track & trace be applied to the food supply chain?

Members of the pharma supply chain and solution vendors have learned a lot about what it will take to meet the DSCSA track and trace requirements. Can those lessons be applied to tracking and tracing in the supply chains of other products, such as food?

Dirk Rodgers is a Contributing Editor for Healthcare Packaging and author of RxTrace.

DSCSA answers are needed

FDA is not addressing the questions people are asking.

More from Dirk Rodgers

Dirk Rodgers, who contributed to Healthcare Packaging’s Pharmaceutical Serialization Playbook, is an independent consultant and founder of RxTrace.

The case for and against RFID in pharma

Reaching necessary read accuracies remains a challenge in pharmaceuticals, but RFID could still prove useful.

Dirk Rodgers, who contributed to Healthcare Packaging’s Pharmaceutical Serialization Playbook, is an independent consultant and founder of RxTrace.

Congress should have mandated randomization

Congress should have mandated randomization of drug serial numbers, but they did not, so it is up to each manufacturer to recognize the importance it would bring to the protection of their brands and of the supply chain.

Dirk Rodgers, who contributed to Healthcare Packaging’s Pharmaceutical Serialization Playbook, is an independent consultant and founder of RxTrace.

RxTrace: Is your drug exempt from the Federal Drug Supply Chain Security Act?

Understanding your product’s characteristics and reading certain provisions of the Drug Supply Chain Security Act are keys.

Dirk Rodgers, who contributed to Healthcare Packaging’s Pharmaceutical Serialization Playbook, is an independent consultant and founder of RxTrace.

The future of healthcare supply chain security

We know more about how healthcare supply chain security will work in 2024 than looking forward in any previous 10-year period.

A perspective on DQSA, preemption, and pedigree

Now that DQSA is law, any previous investments to meet California pedigree law can be repurposed to meet the new federal law.

Figure 1. Manufacturer A is probably acting as a contract manufacturer/packager on behalf of the NDA holder, manufacturer B.

Working with CMOs under California e-pedigree

For different products, manufacturers may fill the role of an exclusive distributor, a contract manufacturing organization, or a repackager. Each of these would be treated differently under the California law with respect to pedigree origination and updating.

WATCH A NARRATED SLIDE SHOW AT hcpgo.to/013

Pharmaceutical serialization: Should you wait?

Exclusive Healthcare Packaging survey reveals half have yet to begin serialization projects, and more than 25% don’t plan to spend money on serialization this year!